NCT03412812: A Dose Escalation Trial of Five Fraction Stereotactic Radiation Therapy for Brain Metastases

NCT03412812
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER++, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Radiation therapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: 
Exclusions: Patients with a history of surgery or radiation to tumor of interest
https://ClinicalTrials.gov/show/NCT03412812

Comments are closed.

Up ↑